Wuji Wan ameliorates ulcerative colitis by restoring impaired membrane transport
Frontiers in Pharmacology · 27.01.2026 · 17
DOI: 10.3389/fphar.2026.1718919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.01.2026. Verfasst von Jianyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Wuji Wan (WJW) is a classical Chinese formula traditionally prescribed for diarrhea/dysentery and abdominal pain. In ulcerative colitis (UC), inflammatory diarrhea reflects not only mucosal inflammation but also inflammation-linked disruption of epithelial electrolyte and water handling, highlighting membrane transport as a mechanistic bridge between symptom burden and immune activation. However, it remains unclear whether WJW confers therapeutic benefit in UC and whether any benefit is accompanied by coordinated regulation of membrane-transport–linked pathways. This study therefore asked whether WJW shows therapeutic effects in a UC model and whether these effects are accompanied by changes in epithelial Na + /Cl − transport and water-channel programs and by modulation of the T-cell–linked potassium channel Kv1.3.
Methods
We investigated this question in a mouse model of DSS-induced colitis (3% dextran sulfate sodium). Our assessment included disease activity index (DAI) scores, histopathological analysis, ELISA, Western blotting, untargeted metabolomics, and whole-cell patch-clamp electrophysiology.
Results
WJW significantly ameliorated DSS-induced colitis, as reflected by improved colonic pathology and partial normalization of DSS-associated serum metabolic perturbations. Untargeted metabolomics highlighted transport-related pathways. WJW increased/normalized the expression of key epithelial transport proteins involved in Na + /Cl − absorption and water handling, including sodium/hydrogen exchanger 3 (NHE3), epithelial sodium channel (ENaC), downregulated in adenoma (DRA), aquaporin-3 (AQP3), and aquaporin-8 (AQP8). In parallel, WJW reduced IL-6, IL-17A, and IFN-γ and dampened ERK/NF-κB pathway activation. WJW also reduced colonic Kv1.3 protein expression, and WJW-containing plasma directly inhibited Kv1.3 currents in Jurkat T cells.
Conclusion
WJW ameliorated DSS-induced colitis and was accompanied by coordinated modulation of epithelial and immune membrane-transport–linked readouts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zitieren
APA
Zhang, J., Zhang, Y., Guo, Y., Sun, Y., Li, Y., Li, Q., Chen, Y., Wang, Y., Yang, Q., Zhang, M., Weng, X., & Deng, Z. (2026). Wuji Wan ameliorates ulcerative colitis by restoring impaired membrane transport. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1718919
Vancouver
Zhang J, Zhang Y, Guo Y, Sun Y, Li Y, Li Q, et al. Wuji Wan ameliorates ulcerative colitis by restoring impaired membrane transport. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1718919
BibTeX
@article{Zhang2026,
author = {Zhang, Jianyu and Zhang, Yang and Guo, Yuxuan and Sun, Yi and Li, Yujie and Li, Qi and Chen, Ying and Wang, Yajie and Yang, Qing and Zhang, Meiyu and Weng, Xiaogang and Deng, Zhihao},
title = {Wuji Wan ameliorates ulcerative colitis by restoring impaired membrane transport},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1718919}
}
EUVIMED